Recent laboratory tests have confirmed ACTIVE 2.0’s revolutionary efficacy fighting killer bacteria such as Serratia Marcescens, which recently caused the death of a newborn baby in an Italian hospital.

The Iris Ceramica Group’s R&D department has been working on the development and monitoring of the technology for a long time, and recently conducted new tests assessing its effect on a real-life case.
The samples, sent to the Artest laboratory in Modena, produced a positive outcome, demonstrating the product’s efficacy against this bacterium too.
This confirmation is of primary importance supporting application of Active Clean Air & Antibacterial Ceramic™ materials in hospitals and other healthcare facilities with particularly high standards of cleanliness and sanitation.
This important milestone once more demonstrates the Group’s focus on designing products that make a significant contribution to the wellbeing of individuals and the community.

Need more information? Contact us!

DISCLAIMER: The Active Surface brand is not available for import, purchase or distribution in the United States of America and territories.
Any and all product claims and descriptions contained on this website or in other sales or promotional materials regarding the Active Surfaces brand, including claims and descriptions of its public health benefits and antimicrobial or antibacterial effects, are not applicable in the US states and territories .

Our web site uses cookies to improve your browsing experience.
For more information on cookies and how to control enabling of cookies with your browser settings, please view our "Cookie Policy".